Research Training in Pediatric Oncology

儿科肿瘤学研究培训

• 批准号: 9123534
• 负责人: SCOTT A ARMSTRONG
• 金额: $ 47.15万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-13 至 2019-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9123534
• 关键词: Pediatric Oncology; Research Training

DESCRIPTION (provided by applicant): This is a competitive renewal application for training grant support in pediatric oncology. The goal of this T32 program is to train physicians who will be the future academic leaders in basic and/or clinical pediatric oncology research and who will work to reduce the burden of cancer in the pediatric population. To accomplish this goal we have engaged a diverse and outstanding training faculty that embraces multiple areas of basic ("wet bench"), translational and clinical research. This experienced and highly accomplished group includes members of the Department of Pediatric Oncology at the Dana-Farber Cancer Institute (DFCI), the Division of Pediatric Hematology/Oncology at Boston Children's Hospital (BCH), and additional components of the Harvard Medical School (HMS). Particular emphasis is placed on close mentorship of trainees in the selection of mentors and in on-going oversight during their research. The T32 program provides training in oncology research at the postdoctoral level for 8 trainees, selected from the combined DFCI-BCH pediatric hematology/oncology fellowship program, who are in their second, third and fourth years of training. The program is committed to identifying and supporting the most promising fellows, including minority candidates. Over the past 45 years the DFCI-BCH fellowship program has trained over 200 individuals, many of whom are leaders of academic pediatric hematology/oncology programs. Continued T32 support will ensure the training of investigational pediatric oncologists, whose research will contribute immeasurably to the understanding and management of childhood cancers.

描述（由申请人提供）：这是儿科肿瘤学培训补助金支持的竞争性续期申请。这个T32计划的目标是培养医生谁将是未来的学术领导者在基础和/或临床儿科肿瘤学研究，谁将努力减少癌症的负担在儿科人群。为了实现这一目标，我们聘请了一个多元化和优秀的培训教师，包括基础（“湿台”），转化和临床研究的多个领域。这个经验丰富、成就卓著的团队包括丹娜-法伯癌症研究所（DFCI）儿科肿瘤科、波士顿儿童医院（BCH）儿科血液学/肿瘤科以及哈佛医学院（HMS）其他组成部分的成员。特别强调在选择导师和在研究期间持续监督时对学员的密切指导。T32计划为8名学员提供博士后水平的肿瘤学研究培训，这些学员是从DFCI-BCH儿科血液学/肿瘤学奖学金计划中选出的，他们正在接受第二，第三和第四年的培训。该计划致力于识别和支持最有前途的研究员，包括少数民族候选人。在过去的45年中，DFCI-BCH奖学金计划已经培训了200多名个人，其中许多人是学术儿科血液学/肿瘤学项目的领导者。持续的T32支持将确保对研究型儿科肿瘤学家的培训，他们的研究将对儿童癌症的理解和管理做出不可估量的贡献。